Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)
Clinical trial NCT05146687 · COMPLETED
Trial details
- NCT number
- NCT05146687
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-15
- Primary completion
- 2020-12-11
- Enrollment
- 369600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.